Legal groups provide pathways to reducing coronavirus spread in carceral settings.
This researcher has some ideas about what we need to do to address the problem.
Two researchers discuss their analysis of Philadelphia FIGHT’s HIV pre-exposure prophylaxis (PrEP) program for cisgender women.
Dr. Melanie Thompson discusses what’s happening in the state around coronavirus, and what it means for people living with HIV.
VOCAL-NY has kept its doors open through the COVID-19 pandemic to serve people who use drugs and may be living with hepatitis C, but how it provides services has changed.
Telemedicine is helping keep transgender patients connected to care, but gaps still exist.
Addressing Coronavirus in African Countries With High HIV Rates: An Interview With UNAIDS Head Winnie Byanyima
Byanyima discusses COVID-19, HIV, and the power of the community response.
Retire? No, Thanks! This Doc Instead Moved to West Virginia to Fight HIV, Hepatitis C, and the Opioid Crisis
In a poor and conservative state, Judith Feinberg, M.D., aims to expand harm reduction—and bring treatment to active drug users.
Using data from the ADVANCE trial, this researcher suggests people with HIV with low-level viremia may still get to undetectable.
Descovy’s approval for PrEP showcases real-life ramifications of leaving trans people out of research. But including trans people is about more than just saying trans people are welcome, says researcher Brian Minalga.